CN103446518B - 一种含有氢溴酸右美沙芬的药物组合物 - Google Patents
一种含有氢溴酸右美沙芬的药物组合物 Download PDFInfo
- Publication number
- CN103446518B CN103446518B CN201310343416.9A CN201310343416A CN103446518B CN 103446518 B CN103446518 B CN 103446518B CN 201310343416 A CN201310343416 A CN 201310343416A CN 103446518 B CN103446518 B CN 103446518B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- cough
- chinese medicine
- dextromethorphan hydrobromide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 title claims abstract description 14
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 7
- 239000003814 drug Substances 0.000 claims abstract description 48
- 229940079593 drug Drugs 0.000 claims abstract description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 5
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 5
- 206010011224 Cough Diseases 0.000 abstract description 55
- 239000000203 mixture Substances 0.000 abstract description 7
- 241001633574 Adenophora stricta Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000205754 Colocasia esculenta Species 0.000 abstract 1
- 235000006481 Colocasia esculenta Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 241000490229 Eucephalus Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241000107360 Vincetoxicum glaucescens Species 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 15
- 238000000034 method Methods 0.000 description 7
- 239000013558 reference substance Substances 0.000 description 7
- 238000009835 boiling Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000954 anitussive effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010061245 Internal injury Diseases 0.000 description 4
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical group O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- SWWQQSDRUYSMAR-UHFFFAOYSA-N 1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol;hydrochloride Chemical group Cl.C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 SWWQQSDRUYSMAR-UHFFFAOYSA-N 0.000 description 1
- QNVKOSLOVOTXKF-UHFFFAOYSA-N 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;hydron;chloride Chemical compound Cl.NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1 QNVKOSLOVOTXKF-UHFFFAOYSA-N 0.000 description 1
- 239000012848 Dextrorphan Substances 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 241000229722 Perilla <angiosperm> Species 0.000 description 1
- 241001092500 Photinia x fraseri Species 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000985 ambroxol hydrochloride Drugs 0.000 description 1
- 229960000386 benzocaine hydrochloride Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- JAQUASYNZVUNQP-PVAVHDDUSA-N dextrorphan Chemical compound C1C2=CC=C(O)C=C2[C@@]23CCN(C)[C@@H]1[C@H]2CCCC3 JAQUASYNZVUNQP-PVAVHDDUSA-N 0.000 description 1
- 229950006878 dextrorphan Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000008876 liujunzi Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- INAXVFBXDYWQFN-XHSDSOJGSA-N morphinan Chemical class C1C2=CC=CC=C2[C@]23CCCC[C@H]3[C@@H]1NCC2 INAXVFBXDYWQFN-XHSDSOJGSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 238000013515 script Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗咳嗽的中西药结合的组合物,其中由西药和中药组成,西药为氢溴酸右美沙芬,中药的原料药的重量配比如下:百合17份,桂枝9份,厚朴12份,鱼腥草14份,桃仁10份,甘草7份,连翘6份,白前12份,茯苓15份,细辛6份,沙参3份,知母14份,麻黄10份,贝母13份,桔梗20份,黄芩16份,薄荷15份,百部14份,金银花16份,当归3份,山楂15份,砂仁7份,山药5份,紫苑10份,氢溴酸右美沙芬和中药的重量比例大约为1:40。
Description
技术领域
本发明涉及一种治疗咳嗽的中西药结合的组合物。
背景技术
肺系疾患的主要证候之一就是咳嗽。纵观历史,历代医家对于咳嗽都有不同见解。《黄帝内经》提出“五脏六腑皆令人咳,非独肺也”的论证”。《景岳全书》又论“咳嗽一证,窃见诸家立论大繁,皆不得其要,多致后人临证莫知所从,所以治难得效”。张景岳将咳嗽证由分为外感、内伤两类。《河间六书》中又提及“寒暑燥湿风火六气,皆令人咳”。咳嗽既是病又是证候,任何年龄均可发病,冬春季节多见。咳嗽的病因有外感、内伤之别,风、寒、暑、湿、燥、火六淫之邪侵袭肺系引起的咳嗽,为外感咳嗽,外邪中又以风、寒、热咳嗽居多,并常以风为先号,挟寒或挟热、挟燥犯肺,发生风寒或风热、风燥等咳嗽;由于肺脏亏虚与其他脏腑功能失调影响到肺而引起的咳嗽,为内伤咳嗽。临床上常内伤、外感咳嗽互见并互为因果。正如《医学心语·咳嗽》所说:“肺体属金,譬若钟然,钟非叩不鸣,风寒暑湿燥火六淫之邪自外击之则鸣,劳欲情志,饮食炙煿之火自内攻之则亦鸣”。
咳嗽以八纲辨证为纲,首辨外感与内伤,以外感咳嗽多见,以宣发肺气为基本原则。汪受传将小儿外感咳嗽分为风寒和风热两大证型,韩新民将其分为风寒、风热和风燥三大证型,其中风寒咳嗽以疏风散寒、宣肺止咳为治法,以金沸草散加减; 风热咳嗽以疏散风热、宣肺止咳为治法,以桑菊饮加减; 风燥咳嗽以疏风清肺、润肺止咳为治法,以清燥救肺汤加减。钟华等则依据小儿体质辨治外感咳嗽,将其分为四型即正常质儿、痰湿质儿、气虚质儿和阴虚质儿,正常质儿以疏散外邪、宣肺止咳为治法,以杏苏散、桑菊饮及麻杏石膏汤等为主方; 痰湿质儿以健脾燥湿、化痰止咳为治法,以麻杏二陈汤为主方; 气虚质儿以疏风宣肺、化痰止咳、佐以健脾益气为治法,在风寒或风热基本方上酌情加用白术、黄芪等益气药,或六君子汤加射干、鱼腥草、连翘、桔梗等。
CN102078558A公开了一种治疗咳嗽的药物组合物,其中原料药的重量配比如下:钩藤30份,天竺黄40份,桔梗10份,砂仁50份,陈皮50份,茯苓10份,薄荷50份,甘草20份,牛黄7份。
CN101991802A公开了一种治疗感冒咳嗽的中药制剂,其含有金银花30份,陈皮30份,茵陈25份,百部35份,甘草30份,苦杏仁25份,柏子仁25份,贝母20份,桔梗30份,大枣20份,干艾叶15份及适量的蜂蜜。
氢溴酸右美沙芬是瑞士Hoffman Roche公司于1950年通过对吗啡结构改造人工合成的右旋性吗啡喃衍生物,作为异构体,其左旋性化合物有镇痛作用,右旋物即美沙芬没有镇痛作用而具有明显的镇咳作用。动物和临床研究表明,美沙芬是一种有效的中枢镇咳药,主要作用于延髓咳嗽中枢,镇咳作用与相同剂量的可待因相当,且不抑制呼吸中枢,无成瘾性,在尿中以美沙芬原形或去甲基代谢物右吗喃被排泄,其毒性低、不良反应少,因此广泛用于各种原因引起的咳嗽。
CN1565525A公开了一种中西药复方糖锭制剂,其由中药浸膏、西药、糖、香精和食用矿物油组成,其中中药浸膏为枇杷叶浸膏或草珊瑚浸膏,西药选自美沙芬溴氢酸、苯佐卡因或盐酸氨溴索。
发明内容
本发明提供了一种用于治疗咳嗽的中西药结合的药物组合物,其中由西药和中药组成,西药为氢溴酸右美沙芬,中药的原料药的重量配比如下:
百合17份,桂枝9份,厚朴12份,鱼腥草14份,桃仁10份,甘草7份,连翘6份,白前12份,茯苓15份,细辛6份,沙参3份,知母14份,麻黄10份,贝母13份,桔梗20份,黄芩16份,薄荷15份,百部14份,金银花16份,当归3份,山楂15份,砂仁7份,山药5份,紫苑10份。
氢溴酸右美沙芬和中药的重量比例为1:40。
上述中药的制备方法为取以上原料药,放入容器中,加冷水漫过药面,浸泡15~20分钟,再加水没过药面约8厘米,进行煎煮。未沸前采用武火煎煮,沸后用文火煎煮20~30分钟;第二次煎煮,水沸后文火煎煮15~20分钟。两次煎煮去渣取汁,合并。
申请人意外地发现,氢溴酸右美沙芬和上述中药的组合物对于治疗咳嗽具有协同效果,组合物对于咳嗽的治疗效果远远好于单一的氢溴酸右美沙芬或上述中药,具有预料不到的技术效果。
具体实施方式
实施例1
药物组合物中西药为氢溴酸右美沙芬2.5克
中药的原料药的重量配比如下,共计100克:
百合17份,桂枝9份,厚朴12份,鱼腥草14份,桃仁10份,甘草7份,连翘6份,白前12份,茯苓15份,细辛6份,沙参3份,知母14份,麻黄10份,贝母13份,桔梗20份,黄芩16份,薄荷15份,百部14份,金银花16份,当归3份,山楂15份,砂仁7份,山药5份,紫苑10份。
氢溴酸右美沙芬和中药的重量比例为1:40。
中药的制备方法为取以上原料药,放入容器中,加冷水漫过药面,浸泡15~20分钟,再加水没过药面约8厘米,进行煎煮。未沸前采用武火煎煮,沸后用文火煎煮20~30分钟;第二次煎煮,水沸后文火煎煮15~20分钟。两次煎煮去渣取汁,合并。
对照品1
氢溴酸右美沙芬
对照品2
百合17份,桂枝9份,厚朴12份,鱼腥草14份,桃仁10份,甘草7份,连翘6份,白前12份,茯苓15份,细辛6份,沙参3份,知母14份,麻黄10份,贝母13份,桔梗20份,黄芩16份,薄荷15份,百部14份,金银花16份,当归3份,山楂15份,砂仁7份,山药5份,紫苑10份。
对照品3
CN102078558A公开的治疗咳嗽的药物组合物,其中原料药的重量配比如下:钩藤30份,天竺黄40份,桔梗10份,砂仁50份,陈皮50份,茯苓10份,薄荷50份,甘草20份,牛黄7份。
对照品4
CN1565525A公开的中西药复方糖锭制剂,其中中药浸膏为枇杷叶浸膏,西药选自美沙芬溴氢酸,二者重量比例为20:1。
实验例2:对二氧化硫烟雾致小鼠咳嗽模型的镇咳作用
将18-22 g的小鼠随机分为7组,模型对照组给予灌胃生理盐水,受试组给予灌胃实施例1和对照品1-4所述药物样品,阳性对照组给予诃子汤水提物,连续给药5天。于末次给药后30分钟,将小鼠置密闭玻璃箱内,定量喷入硫磺燃烧生成的烟雾诱导致咳,记录小鼠咳嗽潜伏期和3分钟内咳嗽次数,结果受试组实施例1平均咳嗽潜伏期均延长50秒以上、平均咳嗽次数明显减少,受试组对照品1-4平均咳嗽潜伏期均延长10秒以上、平均咳嗽次数较多,表明本发明药物样品有明显镇咳作用,优于诃子甘桔汤水提物和对照品1-4。实验结果如表1所示。
表1 本发明药物样品对二氧化硫烟雾致小鼠咳嗽的镇咳作用( ±S,n=15)
注:与模型组比较,*P<0.05,**P<0.01
实施例3临床治疗效果:
疗效标准:疗效判断主要依据为咳嗽症状是否消失。用药15天为1个疗程。具体疗效分以下三级:治愈——咳嗽症状全部消失;好转——咳嗽症状明显减轻;无效——用药1个疗程后,咳嗽症状毫无消失。
效果:用本发明药物治疗咳嗽患者44例,治疗1个疗程,其中治愈43例,好转1例,治愈率为97.7%,有效率为100%。
典型病例:
钱某,男,53岁,农民。2007年1月就诊。患者自述,犯咳嗽病已有一年多。症状咳嗽气短,咽痛,微恶风寒。苔薄白,舌尖红,脉浮数。采用本发明药物,先服10天,症状明显好转,后续服5天,痊愈。2个月追访,未见复发。
Claims (1)
1.一种药物组合物,其中由西药和中药组成,西药为氢溴酸右美沙芬,中药的原料药的重量配比如下:
百合17份,桂枝9份,厚朴12份,鱼腥草14份,桃仁10份,甘草7份,连翘6份,白前12份,茯苓15份,细辛6份,沙参3份,知母14份,麻黄10份,贝母13份,桔梗20份,黄芩16份,薄荷15份,百部14份,金银花16份,当归3份,山楂15份,砂仁7份,山药5份,紫菀10份,
氢溴酸右美沙芬和中药的重量比例为1:40。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310343416.9A CN103446518B (zh) | 2013-08-08 | 2013-08-08 | 一种含有氢溴酸右美沙芬的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310343416.9A CN103446518B (zh) | 2013-08-08 | 2013-08-08 | 一种含有氢溴酸右美沙芬的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103446518A CN103446518A (zh) | 2013-12-18 |
CN103446518B true CN103446518B (zh) | 2015-06-03 |
Family
ID=49729630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310343416.9A Expired - Fee Related CN103446518B (zh) | 2013-08-08 | 2013-08-08 | 一种含有氢溴酸右美沙芬的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103446518B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101254249B (zh) * | 2008-03-20 | 2011-01-12 | 张辉 | 一种治疗咳嗽痰多症的中西药复方制剂及其生产方法 |
CN102579926A (zh) * | 2012-03-27 | 2012-07-18 | 吴宜谦 | 一种止咳药物的配方及制备方法 |
-
2013
- 2013-08-08 CN CN201310343416.9A patent/CN103446518B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103446518A (zh) | 2013-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102631610B (zh) | 一种治疗小儿久咳病的中药 | |
CN102872381B (zh) | 一种治疗流行性腮腺炎的中药组合物 | |
CN102430072A (zh) | 一种治疗咳嗽的中药组合物 | |
CN103393944B (zh) | 治疗咳嗽的中药 | |
CN103394007B (zh) | 治疗咳嗽的中药组合物 | |
CN103394020B (zh) | 治疗咳嗽的组合物 | |
CN103394004B (zh) | 一种治疗咳嗽的中药组合物 | |
CN103349693B (zh) | 一种治疗过敏性鼻炎的外用中药组合物 | |
CN104800549A (zh) | 一种治疗慢性支气管炎的中药组合物 | |
CN103432491B (zh) | 药物组合物 | |
CN103961614A (zh) | 用于治疗呼吸系统疾病的中药组合物及其制备方法和用途 | |
CN103446519B (zh) | 治疗咳嗽的中药组合物 | |
CN103432490B (zh) | 治疗咳嗽的中药组合物 | |
CN103341063B (zh) | 一种治疗风热咳嗽的中药组合物 | |
CN102698165B (zh) | 一种治疗咳嗽、风热袭肺型肺炎的中药 | |
CN104758529A (zh) | 一种治疗风寒感冒的中药组合物 | |
CN104306876A (zh) | 一种治疗风热感冒的中药组合物 | |
CN103394005B (zh) | 用于治疗咳嗽的中药组合物 | |
CN103446518B (zh) | 一种含有氢溴酸右美沙芬的药物组合物 | |
CN103550642B (zh) | 一种治疗风热犯肺所致风温肺热病的中药组合物 | |
CN103463535B (zh) | 一种用于治疗咳嗽的中药组合物 | |
CN103432489B (zh) | 含有氢溴酸右美沙芬的药物组合物 | |
CN105327182A (zh) | 一种治疗儿童百日咳的药物及其制备方法 | |
CN103394006B (zh) | 一种中药组合物 | |
CN103877169B (zh) | 一种治疗咳嗽的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221223 Address after: No. 168, Jinshan Road, Luoxi Street, Linyi Hi tech Industrial Development Zone, Shandong 276000 Patentee after: Shandong Runmeng Emergency Rescue Equipment Co.,Ltd. Address before: No. 8, Yingbin Road, Software Park, Development Zone, Hai'an County, Jiangsu Province 226600 Patentee before: HAIAN CHANGZHOU UNIVERSITY TECHNOLOGY TRANSFER CENTER Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150603 |
|
CF01 | Termination of patent right due to non-payment of annual fee |